All - 202,726 Studies Found
Recruiting |
: Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study. :
|
Recruiting |
: Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors :
: 2016-04-20 : Drug: Pasireotide LAR Pasireotide LAR (SIGNIFOR® LAR) |
Terminated |
: Pasireotide Therapy in Patients With Nelson's Syndrome : Nelson Syndrome : 2012-06-08 : Drug: Pasireotide 4 Weeks pasireotide 0.6mg s/c injections twice daily followed by 24 weeks treatment wi |
Terminated |
: Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin :
: Drug: pasireotide LAR Investigational drug pasireotide LAR was supplied in vials with 20 mg or 40 mg pow |
Completed |
: An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome : Cushing's Syndrome : 2009-07-09 : Drug: mifepristone Mifepristone 300 mg to 1200 mg once daily |
Completed |
: A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome : Cushing's Syndrome : 2007-12-05 : Drug: mifepristone Patients take mifepristone by mouth once a day. The dose is increased during schedule |
Recruiting |
: Study to Evaluate CORT125134 in Patients With Cushing's Syndrome : Cushing's Syndrome : 2016-06-15 : Drug: CORT125134 |
Enrolling by invitation |
: Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome : Cushing's Syndrome : 2016-01-08 : Other: No intervention No treatment (intervention) was administered. |
Recruiting |
: Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome :
|
Recruiting |
: Study of Adrenal Gland Tumors : Adrenal Gland Neoplasm : 2000-06-28 |